263 related articles for article (PubMed ID: 12955642)
1. Outcome and management of hepatitis C in liver transplant recipients.
Chan SE; Rosen HR
Clin Infect Dis; 2003 Sep; 37(6):807-12. PubMed ID: 12955642
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
3. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of recurrent HCV infection after liver transplantation].
Ostojić R
Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
[TBL] [Abstract][Full Text] [Related]
6. Management of recurrence of hepatitis C infection following liver transplantation.
Charlton M
Minerva Chir; 2003 Oct; 58(5):717-24. PubMed ID: 14603150
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression, liver injury and post-transplant HCV recurrence.
Ciesek S; Wedemeyer H
J Viral Hepat; 2012 Jan; 19(1):1-8. PubMed ID: 22187942
[TBL] [Abstract][Full Text] [Related]
8. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
García-Reyne A; Lumbreras C; Fernández I; Colina F; Abradelo M; Magan P; San-Juan R; Manrique A; López-Medrano F; Fuertes A; Lizasoain M; Moreno E; Aguado JM
Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
[TBL] [Abstract][Full Text] [Related]
9. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
10. [The course of hepatitis C infection after liver transplantation].
Ołdakowska-Jedynak U; Paczek L
Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439
[TBL] [Abstract][Full Text] [Related]
11. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
12. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis C virus in the transplant patient.
Berenguer M
Clin Liver Dis; 2007 May; 11(2):355-76. PubMed ID: 17606212
[TBL] [Abstract][Full Text] [Related]
15. Management of posttransplant hepatitis C infection.
Aytaman A; Kaufman M; Terrault NA
Curr Opin Organ Transplant; 2010 Jun; 15(3):301-9. PubMed ID: 20445452
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
17. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
Martin P; Busuttil RW; Goldstein RM; Crippin JS; Klintmalm GB; Fitzsimmons WE; Uleman C
Liver Transpl; 2004 Oct; 10(10):1258-62. PubMed ID: 15376310
[TBL] [Abstract][Full Text] [Related]
18. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation.
Pelletier SJ; Raymond DP; Crabtree TD; Iezzoni JC; Sawyer RG; Hahn YS; Pruett TL
Hepatology; 2000 Aug; 32(2):375-81. PubMed ID: 10915745
[TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
Kuo A; Terrault NA
J Hepatol; 2007 Mar; 46(3):359-61. PubMed ID: 17223220
[No Abstract] [Full Text] [Related]
20. Course and treatment of recurrent Hepatitis C after liver transplantation.
Neumann UP; Neuhaus P
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):61-6. PubMed ID: 15719007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
